PH20622A - Process and intermediates for preparing pirbuterol and analogs - Google Patents

Process and intermediates for preparing pirbuterol and analogs

Info

Publication number
PH20622A
PH20622A PH26843A PH26843A PH20622A PH 20622 A PH20622 A PH 20622A PH 26843 A PH26843 A PH 26843A PH 26843 A PH26843 A PH 26843A PH 20622 A PH20622 A PH 20622A
Authority
PH
Philippines
Prior art keywords
analogs
intermediates
pirbuterol
preparing
preparing pirbuterol
Prior art date
Application number
PH26843A
Other languages
English (en)
Inventor
Berkeley Wendell Cue Jr
Stephen Sargent Massett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH20622A publication Critical patent/PH20622A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH26843A 1981-02-09 1982-02-09 Process and intermediates for preparing pirbuterol and analogs PH20622A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23292381A 1981-02-09 1981-02-09

Publications (1)

Publication Number Publication Date
PH20622A true PH20622A (en) 1987-03-06

Family

ID=22875140

Family Applications (4)

Application Number Title Priority Date Filing Date
PH26843A PH20622A (en) 1981-02-09 1982-02-09 Process and intermediates for preparing pirbuterol and analogs
PH29713A PH19167A (en) 1981-02-09 1983-10-19 Process and intermediate for preparing pirbuterol
PH29712A PH20292A (en) 1981-02-09 1983-10-19 Processes and intermediates for preparing pirbuterol and analogs
PH29714A PH19164A (en) 1981-02-09 1983-10-19 Process and intermediate for preparing pirbuterol

Family Applications After (3)

Application Number Title Priority Date Filing Date
PH29713A PH19167A (en) 1981-02-09 1983-10-19 Process and intermediate for preparing pirbuterol
PH29712A PH20292A (en) 1981-02-09 1983-10-19 Processes and intermediates for preparing pirbuterol and analogs
PH29714A PH19164A (en) 1981-02-09 1983-10-19 Process and intermediate for preparing pirbuterol

Country Status (26)

Country Link
EP (4) EP0058071B1 (es)
JP (4) JPS57150665A (es)
KR (1) KR860000623B1 (es)
AR (4) AR231439A1 (es)
AT (2) ATE21691T1 (es)
AU (1) AU530826B2 (es)
CA (1) CA1179677A (es)
CS (1) CS229678B2 (es)
DD (2) DD202544A5 (es)
DE (2) DE3272061D1 (es)
DK (1) DK157541C (es)
EG (1) EG16242A (es)
ES (4) ES8305721A1 (es)
FI (1) FI820396L (es)
GR (1) GR75867B (es)
GT (1) GT198273686A (es)
IE (2) IE52326B1 (es)
IL (1) IL64954A (es)
NO (4) NO820371L (es)
NZ (1) NZ199646A (es)
PH (4) PH20622A (es)
PL (4) PL130917B1 (es)
PT (1) PT74397B (es)
SU (4) SU1194273A3 (es)
YU (3) YU42756B (es)
ZA (1) ZA82778B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (de) * 1986-05-06 1987-11-12 Bayer Ag Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
BE795937A (fr) * 1972-03-01 1973-08-27 Pepro Procede d'hydroxymethylation d'une 3-hydroxy-pyridine substituee
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US4031108A (en) * 1974-10-09 1977-06-21 Pfizer Inc. 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
PH20292A (en) 1986-11-18
JPS6059911B2 (ja) 1985-12-27
NO824274L (no) 1982-08-10
GR75867B (es) 1984-08-02
ES518973A0 (es) 1984-03-01
PT74397A (en) 1982-03-01
ES8403112A1 (es) 1984-03-01
DD202544A5 (de) 1983-09-21
SU1194273A3 (ru) 1985-11-23
AR229374A1 (es) 1983-07-29
YU42756B (en) 1988-12-31
SU1217253A3 (ru) 1986-03-07
PL130678B1 (en) 1984-08-31
PL239426A1 (en) 1983-04-25
ATE21691T1 (de) 1986-09-15
IE52326B1 (en) 1987-09-16
FI820396L (fi) 1982-08-10
PL239427A1 (en) 1983-04-25
DE3272793D1 (en) 1986-10-02
IL64954A (en) 1986-03-31
ES509430A0 (es) 1983-04-16
EP0058072A3 (en) 1982-08-25
AR231439A1 (es) 1984-11-30
PL239428A1 (en) 1983-04-25
PH19167A (en) 1986-01-16
PL235000A1 (en) 1983-04-11
JPS6135184B2 (es) 1986-08-12
DD210034A5 (de) 1984-05-30
NZ199646A (en) 1985-11-08
JPS60208962A (ja) 1985-10-21
AU8027182A (en) 1982-08-19
EP0058070A2 (en) 1982-08-18
AR229712A1 (es) 1983-10-31
ES8403111A1 (es) 1984-03-01
AR229373A1 (es) 1983-07-29
KR860000623B1 (ko) 1986-05-24
EP0058071A3 (en) 1982-08-25
ES8403110A1 (es) 1984-03-01
JPS6119624B2 (es) 1986-05-17
AU530826B2 (en) 1983-07-28
EP0058069B1 (en) 1986-08-27
IL64954A0 (en) 1982-04-30
IE52325B1 (en) 1987-09-16
YU42908B (en) 1988-12-31
YU43389B (en) 1989-06-30
CA1179677A (en) 1984-12-18
JPS60208964A (ja) 1985-10-21
PL130580B1 (en) 1984-08-31
PH19164A (en) 1986-01-16
JPS6059231B2 (ja) 1985-12-24
EP0058070A3 (en) 1982-08-25
DE3272061D1 (en) 1986-08-28
IE820273L (en) 1982-08-09
YU201884A (en) 1985-04-30
YU26682A (en) 1985-04-30
NO824275L (no) 1982-08-10
KR830009028A (ko) 1983-12-17
YU201984A (en) 1985-04-30
NO820371L (no) 1982-08-10
ES518971A0 (es) 1984-03-01
GT198273686A (es) 1983-07-30
JPS6193164A (ja) 1986-05-12
ATE20882T1 (de) 1986-08-15
EP0058069A2 (en) 1982-08-18
CS229678B2 (en) 1984-06-18
SU1240354A3 (ru) 1986-06-23
DK157541B (da) 1990-01-22
NO824273L (no) 1982-08-10
EP0058071A2 (en) 1982-08-18
PL130918B1 (en) 1984-09-29
IE820275L (en) 1982-08-09
EP0058069A3 (en) 1982-09-01
EP0058072A2 (en) 1982-08-18
ES8305721A1 (es) 1983-04-16
SU1250170A3 (ru) 1986-08-07
EP0058071B1 (en) 1986-07-23
ES518972A0 (es) 1984-03-01
PT74397B (en) 1984-10-09
DK157541C (da) 1990-06-11
PL130917B1 (en) 1984-09-29
JPS57150665A (en) 1982-09-17
DK52182A (da) 1982-09-17
EG16242A (en) 1989-01-30
ZA82778B (en) 1983-01-26

Similar Documents

Publication Publication Date Title
PT74504B (en) Process for preparing imidazodiazepines
EP0070140A3 (en) Improved distillation process
YU194982A (en) Process for preparing new benzoheterocycles
DE3268413D1 (en) Process for preparing chlorotrifluoromethylbenzene
DE3261535D1 (en) Process for preparing aryldiazosulphonates
PT75680A (en) Process for preparing 5-phenyl-2s-pentanol
DE3261580D1 (en) Process for preparing 4-haloazetidin-2-ones
PT72823A (en) Process for preparing antidepressant pyrrolylpiperidines
PT75315A (en) Process for preparing novel 2-cyanosteroids
EG16242A (en) Process and intermediates for preparing pirbuterol and analogs
GB2112777B (en) Process for preparing mononitrochlorobenzene
DE3262826D1 (en) Process for preparing m-alkylhydroxybenzene
DE3267381D1 (en) Process for preparing beta-chloroalanine
DE3263884D1 (en) Process for preparing alpha-omega-bis-flurosulfato-perfluoroalkanes
DE3260363D1 (en) Process for preparing 3-alkylaminophenols
PL237600A1 (en) Process for preparing novel sulfimines
PT72430B (en) Process for preparing substituted anilides
DE3260668D1 (en) Process for preparing butadienedinitriles
DE3263400D1 (en) Process for preparing trialkylsilyldiazomethanes
HU186452B (en) Process for preparing 3-alkyl-derivatives of 1-acyl-carbamides
YU86981A (en) Process for preparing 2-methyl-3-lauroyloxy-4-methoxy-5-acetoxymethyl-pyridine
YU37181A (en) Process for preparing n-aryl-nacyl-3-amino-oxazolidin-2-ones
PL135888B2 (en) Process for preparing 1-substituted-2-oxabenzocycloalkanes
PL232438A1 (en) Process for preparing polydesoxynucleotides
YU78481A (en) Process for preparing beta-methyldigoxin